Pathophysiology from preconception, during pregnancy, and beyond
Date
Authors
Hivert, Marie France
Backman, Helena
Benhalima, Katrien
Catalano, Patrick
Desoye, Gernot
Immanuel, Jincy
McKinlay, Christopher J.D.
Meek, Claire L.
Nolan, Christopher J.
Ram, Uma
Journal Title
Journal ISSN
Volume Title
Publisher
Access Statement
Abstract
Gestational diabetes is the most common medical complication in pregnancy. Historically, gestational diabetes was considered a pregnancy complication involving treatment of rising glycaemia late in the second trimester. However, recent evidence challenges this view. Pre-pregnancy and pregnancy-specific factors influence gestational glycaemia, with open questions regarding roles of non-glycaemic factors in the aetiology and consequences of gestational diabetes. Varying patterns of insulin secretion and resistance in early and late pregnancy underlie a heterogeneity of gestational diabetes in the timing and pathophysiological subtypes with clinical implications: early gestational diabetes and insulin resistant gestational diabetes subtypes are associated with a higher risk of pregnancy complications. Metabolic perturbations of early gestational diabetes can affect early placental development, affecting maternal metabolism and fetal development. Fetal hyperinsulinaemia can affect the development of multiple fetal tissues, with short-term and long-term consequences. Pregnancy complications are prevented by managing glycaemia in early and late pregnancy in some, but not all women with gestational diabetes. A better understanding of the pathophysiology and heterogeneity of gestational diabetes will help to develop novel management approaches with focus on improved prevention of maternal and offspring short-term and long-term complications, from pre-conception, throughout pregnancy, and beyond.
Description
Keywords
Citation
Collections
Source
The Lancet
Type
Book Title
Entity type
Publication